240 related articles for article (PubMed ID: 25839337)
1. Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.
Lee J; Fervaha G; Takeuchi H; Powell V; Remington G
J Clin Psychopharmacol; 2015 Jun; 35(3):237-41. PubMed ID: 25839337
[TBL] [Abstract][Full Text] [Related]
2. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
Lee J; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
Eur Neuropsychopharmacol; 2014 Oct; 24(10):1622-9. PubMed ID: 25156578
[TBL] [Abstract][Full Text] [Related]
3. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
Díaz-Marsá M; Sánchez S; Rico-Villademoros F;
J Clin Psychiatry; 2009 Apr; 70(4):509-17. PubMed ID: 19358789
[TBL] [Abstract][Full Text] [Related]
5. Linking the PANSS, BPRS, and CGI: clinical implications.
Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
[TBL] [Abstract][Full Text] [Related]
6. Is there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysis.
Sawamura J; Morishita S; Ishigooka J
BMC Psychiatry; 2010 Dec; 10():105. PubMed ID: 21134296
[TBL] [Abstract][Full Text] [Related]
7. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
Tang WK; Ungvari GS
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
[TBL] [Abstract][Full Text] [Related]
9. Switching to ziprasidone in the clinical practice setting: an open-label study.
Gutiérrez Fraile M; de la Gándara Martín JJ; Bobes García J
Int J Psychiatry Med; 2013; 45(2):125-42. PubMed ID: 23977817
[TBL] [Abstract][Full Text] [Related]
10. Relationship between symptomatic improvement and overall illness severity in patients with schizophrenia.
Fervaha G; Agid O; Takeuchi H; Lee J; Foussias G; Remington G
J Clin Psychopharmacol; 2015 Apr; 35(2):128-33. PubMed ID: 25679125
[TBL] [Abstract][Full Text] [Related]
11. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.
Samara MT; Engel RR; Millier A; Kandenwein J; Toumi M; Leucht S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1767-72. PubMed ID: 25219937
[TBL] [Abstract][Full Text] [Related]
12. Equipercentile linking of the BPRS and the PANSS.
Leucht S; Rothe P; Davis JM; Engel RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
[TBL] [Abstract][Full Text] [Related]
14. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
Turkoz I; Fu DJ; Bossie CA; Sheehan JJ; Alphs L
J Affect Disord; 2013 Aug; 150(1):17-22. PubMed ID: 23517884
[TBL] [Abstract][Full Text] [Related]
18. The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials.
Leucht S; Engel RR
Neuropsychopharmacology; 2006 Feb; 31(2):406-12. PubMed ID: 16123745
[TBL] [Abstract][Full Text] [Related]
19. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
20. Determinants of patient-rated and clinician-rated illness severity in schizophrenia.
Fervaha G; Takeuchi H; Agid O; Lee J; Foussias G; Remington G
J Clin Psychiatry; 2015 Jul; 76(7):924-30. PubMed ID: 25562591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
